Summary: Microdosing GLP-1 for Hashimoto's is an unapproved, off-label practice lacking clinical evidence, and the NHS does not recommend GLP-1 receptor agonists for thyroid conditions without concurrent type 2 diabetes or obesity meeting specific criteria
If you want to try different forms such as leaves, pods, or flowers, look online or at a store carrying international foods or supplements
With injectible GLP-1s, local reactions like itchiness or redness may occur at the injection site
"While GLP-1 medications affect gastrointestinal tract motility, their quantified impact may not be as significant as previously assumed, said corresponding author, Dr Walter Chan, director of the Center of Gastrointestinal Motility and a physician in the Brigham's Division of Gastroenterology, Hepatology and Endoscopy
How should I monitor my nutrition and hydration
The article says meta-analyses suggest berberine reduces fasting glucose by 10 to 15 mg/dL in type 2 diabetes patients, with HbA1c improvements of roughly 0.5 to 1.0 percentage points